Research Highlights - Spring 2016 Discoveries and Achievements Study offers clues to precision treatments for lukemia Clues to precision treatments for a tough childhood leukemia Researchers reveal genetic secrets of a high-risk pediatric leukemia called Ph-ALL, and find treatment potential in the drug ruxolitinib. A promising anti-inflammatory drug tames the immune system The drug ruxolitinib shows promise in targeting inflammatory reactions in the immune disorder hemophagocytic lymphohistiocytosis (HLH). Parental influence extends to drug response Researchers demonstrate how differences in inherited genetic makeup can cause problems during leukemia treatment. Understanding how brain tumor treatment affects the brain An unprecedented study finds that survivors of childhood brain tumors are at risk of memory and intelligence deficits. A key goal? Catch them early. From Promise, Spring 2016 Donate Now Promise Archive More articles from this issue St. Jude Proton Therapy: Think Positive St. Jude opens the first proton therapy center designed just for children. Going Global: Taking St. Jude to the World St. Jude expands its mission to the most remote parts of the globe. Tyler's Treehouse A little boy's legacy may help save the lives of kids with a rare brain tumor. Accelerating Progress Through Global Collaboration St. Jude prepares to greatly increase the number of children treated on clinical trials such as SJMB12. ProteinPaint: Making Data Beautiful An elegant Web tool developed at St. Jude makes it easy for any scientist to explore cancer genome data. St. Jude Tells Malaria to Buzz Off Scientists and clinicians team up to create a potential malaria drug that could save untold lives worldwide. The Perfect Gift Donate your birthday to help St. Jude kids. Science Students Come to St. Jude Memphis-area high school students and teachers visit St. Jude to get an exclusive look at science in progress.